Overwatch Research Overview
- Founded
-
2017

- Status
-
Acquired/Merged
- Employees
-
15

- Latest Deal Type
-
M&A
- Financing Rounds
-
5
Overwatch Research General Information
Description
Developer of in vivo tracking software designed to transform how scientific researchers manage their experiments while collaborating with their colleagues. The company's laboratory workflow software brings a unique approach to study management with the benefit of time savings and error reduction, enabling scientists to create reproducible research by automating many of the manual activities during in vivo study tracking.
Contact Information
Website
www.overwatchresearch.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Enterprise Systems (Healthcare)
Parent Company
Primary Office
- 18 Ormeau Avenue
- Belfast BT2 8HS
- Northern Ireland, United Kingdom
+44 07894 000000
Overwatch Research Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Overwatch Research Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of in vivo tracking software designed to transform how scientific researchers manage their experiments while c
Enterprise Systems (Healthcare)
Belfast, United Kingdom
15
As of 2022
00.000
000000&0
00.000
Overwatch Research Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
000000 | Venture Capital-Backed | San Francisco, CA | 000 | 000.00 | 00000000000 | 000.00 |
Overwatch Research Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Chris Armstrong Ph.D | Co-Founder & Chief Executive Officer | ||
Graham Wilsdon | Co-Founder & Chief Technical Officer | ||
Paul Wilsdon | Co-Founder & Chief Design Officer |
Overwatch Research Signals
Overwatch Research Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|